Tag: ARIA

Finance

Stock Runners: Ariad Pharmaceuticals (NASDAQ:ARIA), Sony Corp (ADR) (NYSE:SNE), SinoCoking Coal and Coke Chemical Industries (NASDAQ:SCOK), Daxor (NYSEMKT:DXR), Limoneira Company (NASDAQ:LMNR)

On October 24, ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA) announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted its final opinion on Iclusig® (ponatinib) following the recommendations made by the Pharmacovigilance Risk Assessment Committee (PRAC) earlier this month. Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) in last trading activity fell -1.68% to close at $5.87. Company weekly performance is 5.01% … Continue reading Stock Runners: Ariad Pharmaceuticals (NASDAQ:ARIA), Sony Corp (ADR) (NYSE:SNE), SinoCoking Coal and Coke Chemical Industries (NASDAQ:SCOK), Daxor (NYSEMKT:DXR), Limoneira Company (NASDAQ:LMNR)

Colin Pettis
Finance

Whats Hot Today : Ariad Pharmaceuticals Inc. (NASDAQ:ARIA), Halliburton Company (NYSE:HAL), MWI Veterinary Supply, Inc. (NASDAQ:MWIV), K12, Inc. (NYSE:LRN), General Motors (NYSE:GM)

On Oct 15, ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA) announced that it will report its third quarter 2014 financial results on Wednesday, November 5, 2014, before the market opens. Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) belongs to Healthcare sector. Its weekly performance is 6.53%. On last trading day company shares ended up $5.71. Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) distance from 50-day simple moving average (SMA50) is -0.83%. On Oct 20, … Continue reading Whats Hot Today : Ariad Pharmaceuticals Inc. (NASDAQ:ARIA), Halliburton Company (NYSE:HAL), MWI Veterinary Supply, Inc. (NASDAQ:MWIV), K12, Inc. (NYSE:LRN), General Motors (NYSE:GM)

Jayne Crisman
Finance

Today’s Watch List : Ariad Pharmaceuticals Inc. (NASDAQ:ARIA), Oracle Corporation (NYSE:ORCL), JGWPT Holdings Inc. (NYSE:JGW), Argan, Inc. (NYSE:AGX), The Allstate Corporation (NYSE:ALL)

ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA) announced updated clinical results on its investigational tyrosine kinase inhibitor (TKI), AP26113, in patients with advanced non-small cell lung cancer (NSCLC) from an ongoing Phase 1/2 trial. These study results show sustained anti-tumor activity of AP26113 in patients with anaplastic lymphoma kinase (ALK) positive NSCLC, including patients with active brain metastases. The updated Phase 1/2 trial now contains more mature data … Continue reading Today’s Watch List : Ariad Pharmaceuticals Inc. (NASDAQ:ARIA), Oracle Corporation (NYSE:ORCL), JGWPT Holdings Inc. (NYSE:JGW), Argan, Inc. (NYSE:AGX), The Allstate Corporation (NYSE:ALL)

Mark Doerr
Finance

News Buzz : Ariad Pharmaceuticals Inc. (NASDAQ:ARIA), VIVUS Inc. (NASDAQ:VVUS), Miller Energy Resources, Inc. (NYSE:MILL), RCS Capital Corporation (NYSE:RCAP), Fred’s, Inc. (NASDAQ:FRED),

Ariad Pharmaceuticals (NASDAQ:ARIA Director Sarah J. Schlesinger bought 5,200 shares of Ariad Pharmaceuticals stock on the open market in a transaction that occurred on Wednesday, September 10th. The shares were purchased at an average cost of $5.73 per share, with a total value of $29,796.00. Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) belongs to Healthcare sector. Its weekly performance is -3.27%. On last trading day company shares ended … Continue reading News Buzz : Ariad Pharmaceuticals Inc. (NASDAQ:ARIA), VIVUS Inc. (NASDAQ:VVUS), Miller Energy Resources, Inc. (NYSE:MILL), RCS Capital Corporation (NYSE:RCAP), Fred’s, Inc. (NASDAQ:FRED),

Colin Pettis
Finance

Trader’s Recap : Ariad Pharmaceuticals (NASDAQ:ARIA), Trulia (NYSE:TRLA), Hawkins (NASDAQ:HWKN), Compugen Ltd. (NASDAQ:CGEN), Oaktree Capital Group, LLC (NYSE:OAK)

Ariad Pharmaceuticals Inc. (NASDAQ:ARIA)’s Director Alexander J. Denner acquired 850,000 shares of Ariad Pharmaceuticals stock on the open market in a transaction dated Aug. 15. The shares were purchased at an average price of $5.83 per share, for a total transaction of $4,955,500.00. Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) belongs to Healthcare sector. Its weekly performance is -3.46%. On last trading day company shares ended up $6.14. … Continue reading Trader’s Recap : Ariad Pharmaceuticals (NASDAQ:ARIA), Trulia (NYSE:TRLA), Hawkins (NASDAQ:HWKN), Compugen Ltd. (NASDAQ:CGEN), Oaktree Capital Group, LLC (NYSE:OAK)

Jason Knox
Finance

Trending Stocks : Ariad Pharmaceuticals (NASDAQ:ARIA), Checkpoint (NYSE:CKP), Computer Sciences (NYSE:CSC), Seattle Genetics Inc. (NASDAQ:SGEN), Infoblox Inc. (NYSE:BLOX)

US specialty pharma firm Ariad Pharmaceuticals (NASDAQ:ARIA) has granted Israel’s Medison Pharma exclusive rights to commercialize Iclusig (ponatinib) in Israel for patients with Philadelphia-positive (Ph+) leukemias. Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) belongs to Healthcare sector. Its weekly performance is -12.09%. On last trading day company shares ended up $5.38. Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) distance from 50-day simple moving average (SMA50) is -12.94%. Checkpoint Systems, Inc. (NYSE:CKP) … Continue reading Trending Stocks : Ariad Pharmaceuticals (NASDAQ:ARIA), Checkpoint (NYSE:CKP), Computer Sciences (NYSE:CSC), Seattle Genetics Inc. (NASDAQ:SGEN), Infoblox Inc. (NYSE:BLOX)

Mark Doerr